|7337 E. Doubletree Ranch Rd, Suite 100 , Scottsdale, AZ 85258|
|Fund Manager||Team Managed|
Until the day prior to its Target Date (defined below), the Portfolio seeks to provide total return consistent with an asset allocation targeted at retirement in approximately 2055. On the Target Date,the Portfolio's investment objective will be to seek to provide a combination of total return and stability of principal consistent with an asset allocation targeted to retirement. The Portfolio invests primarily in a combination of Underlying Funds, which are actively managed funds or passively managed funds (index funds). The Underlying Funds may or may not be affiliated with the investment adviser. The Underlying Funds invest in U.S. stocks, international stocks, U.S.bonds, and other debt instruments and the Portfolio uses an asset allocation strategy designed for investors expecting to retire around the year 2055. The Portfolio's current approximate target investment allocation (expressed as a percentage of its net assets) (Target Allocation) among the Underlying Funds is as follows: 95% in equity securities and 5% in debt instruments. Although this is the Target Allocation, the actual allocation of the Portfolio's assets may deviate from the percentages shown.
|Asset Type||% Of Allocation|
|Total Net Assets||54.54 M|
|Criteria||3 Years||5 Years||10 Years|
|Minimum Initial IRA||$0|
|Symbol||Company Name||% Of Assets|
|IICFX||VOYA MULTI-MAN INTNL FACTORS||8.96%|
|IEMGX||ING MULTI-MANAGER EMERGING MA||8.50%|
|ITCSX||ING T ROWE PRICE CAP APP PTF||7.61%|
|ISBAX||VY COLUMBIA CONTRARIAN CORE||7.13%|
|IGEAX||ING T ROWE PRICE GROWTH EQ||6.16%|
|IVKIX||VY INVESCO COMSTOCK||4.15%|
|VTV||VANGUARD VALUE ETF||3.86%|
|IMCVX||ING MULTI-MANAGER MIDCAP VAL||2.59%|
|IAXAX||VY T ROWE PRICE DIV MID CP GR||2.42%|
|IIGIX||ING MULTI MANAGER INTL EQ FD||15.58%|
Join the Action Alerts PLUS Community today!
Stocks could drop 20% as fiscal stimulus is withdrawn and economic growth slows, a Morgan Stanley strategist says.
AstraZeneca's breast-cancer treatment reduced the risk of disease progression or death by 72% vs. a currently approved treatment.
Bitcoin and other cryptocurrencies are battered as China Evergrande Group struggles with bond obligations.
Brooks Automation is selling its chip solutions group and said it would no longer pursue splitting into two companies.
DR Horton said "significant disruptions in the supply chain ... along with tightness in the labor market" will lead to a modestly lower full-year sales forecast.
Colgate-Palmolive stock was upgraded to buy with an $86 price target at Deutsche Bank.
Jim Cramer discusses the market selloff, Evergrande, debt ceiling talks, the upcoming Federal Reserve meeting, Pfizer and more in his latest video interview with TheStreet.
Wynn Resorts faces regulatory uncertainty in Macau, but Morgan Stanley says the casino operator is still 'worth the risk.'
Tesla wants to expand its autonomous-driving effort to help cars make their way through cities, not just highways.
Stocks moving in premarket trading Monday include Pfizer, Netflix, Li Auto, AstraZeneca and Bank of America.